Physician-industry conflict of interest: public opinion regarding industry-sponsored research

Clinical article

Restricted access

Object

The nature of physician-industry conflict of interest (COI) has become a source of considerable concern, but is often not discussed in the research setting. With reduced funding available from government and nonprofit sources, industry support has enthusiastically grown, but along with this comes the potential for COI that must be regulated. In this era of shared decision making in health care, society must have input into this regulation. The purpose of this study was to assess the opinions of a North American population sample on COI regarding industry-funded research and to analyze population subgroups for trends.

Methods

A survey was developed for face and content validity, underwent focus group evaluation for clarity and bias reduction, and was administered via the World Wide Web. Demographic and general survey results were summarized as a percentage for each answer, and subgroup analysis was done using logistic regression. Generalizability of the sample to the US population was also assessed.

Results

Of 541 surveys, 40 were excluded due to missing information, leaving 501 surveys for analysis. The sample population was composed of more females, was older, and was more educated than a representative cross-section of the American population. Respondents support multidisciplinary surgeon-industry COI regulation and trust doctors and their professional societies the most to head this effort. Respondents trust government officials and company representatives the least with respect to regulation of COI. Most respondents feel that industry-sponsored research can involve physicians and be both objective and beneficial to patients.

Conclusions

Most respondents in this study felt that surgeons should be involved in industry-sponsored research and that more research, regardless of funding source, will ultimately benefit patients. The majority of respondents distrust government or industry to regulate COI. The development of evidence-based treatment recommendations requires the inclusion of patient preference. The authors encourage regulatory bodies to follow suit and include society's perspective on regulation of COI in research.

Abbreviation used in this paper:COI = conflict of interest.

Article Information

Address correspondence to: Charles Fisher, M.D., M.H.Sc., University of British Columbia, Combined Neurosurgery and Orthopaedic Spine Program, Blusson Spinal Cord Centre, 6th Floor, 818 West 10th Avenue, Vancouver, British Columbia V5Z 1M9, Canada. email: charles.fisher@vch.ca.

Please include this information when citing this paper: published online May 4, 2012; DOI: 10.3171/2012.4.SPINE11869.

© AANS, except where prohibited by US copyright law.

Headings

References

1

Als-Nielsen BChen WGluud CKjaergard LL: Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?. JAMA 290:9219282003

2

American Academy of Orthopaedic Surgeons: Opinions on Ethics and Professionalism Rosemont, ILAmerican Academy of Orthopaedic Surgeons2005. (http://www.aaos.org/about/papers/ethics/1204eth.asp) [Accessed April 9 2012]

3

Bekelman JELi YGross CP: Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289:4544652003

4

Bernard LField MJ: Conflict of Interest in Medical Research Education and Practice Washington, DCNational Academies Press2009

5

Bhandari MBusse JWJackowski DMontori VMSchünemann HSprague S: Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ 170:4774802004

6

Bhandari MJönsson ABühren V: Conducting industry-partnered trials in orthopaedic surgery. Injury 37:3613662006

7

Brand RBuckwalter JACanale STCooney WP IIID'Ambrosia RGrana WA: Patient care, professionalism, and relations with industry. J Orthop Res 26:2792802008

8

Cartwright WS: Methods for the Economic Evaluation of Health Care Programmes, ed 2, by Michael F Drummond, Bernie O'Brien, Greg L. Stoddart, George W. Torrance. Oxford: Oxford University Press, 1997. J Ment Health Policy Econ 2:431999. (Book review)

9

Deyo RAPsaty BMSimon GWagner EHOmenn GS: The messenger under attack—intimidation of researchers by special-interest groups. N Engl J Med 336:117611801997

10

Epps CH Jr: Ethical guidelines for orthopaedists and industry. Clin Orthop Relat Res 412:14202003

11

Ezzet KA: The prevalence of corporate funding in adult lower extremity research and its correlation with reported results. J Arthroplasty 18:7 Suppl 11381452003

12

Fisher CGWood KB: Introduction to and techniques of evidence-based medicine. Spine 32:19 SupplS66S722007

13

Guyatt GHNaylor CDJuniper EHeyland DKJaeschke RCook DJ: Users' guides to the medical literature. Part XII. How to use articles about health-related quality of life. JAMA 277:123212371997

14

Guyatt GVist GFalck-Ytter YKunz RMagrini NSchunemann H: An emerging consensus on grading recommendations?. Evid Based Med 11:242006

15

Hadley MN: Isolated fractures of the axis in adults. Neurosurgery 50:3 SupplS125S1392002

16

The Harris Poll: Doctors and Teachers Most Trusted Among 22 Occupations and Professions: Fewer Adults Trust the President to Tell the Truth Harris Interactive Inc2006. (http://www.b2i.us/profiles/investor/NewsPDF.asp?b=1963&ID=34138&m=rl) [Accessed April 10 2012]

17

Jaquet GJ: Industry CEOs. Relationships with Surgeons are Vital Rosemont, ILAmerican Academy of Orthopaedic SurgeonsJune2009. (http://www.aaos.org/news/aaosnow/jun09/cover2.asp) [Accessed April 9 2012]

18

Khan MHLee JYRihn JACassinelli EHLim MRKang JD: The surgeon as a consultant for medical device manufacturers: what do our patients think?. Spine 32:261626192007

19

Kjaergard LLAls-Nielsen B: Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ 325:2492002

20

Kubiak ENPark SSEgol KZuckerman JDKoval KJ: Increasingly conflicted: an analysis of conflicts of interest reported at the annual meetings of the Orthopaedic Trauma Association. Bull Hosp Jt Dis 63:83872006

21

Levinsky NG: Nonfinancial conflicts of interest in research. N Engl J Med 347:7597612002

22

Moore J: Part I: Medical device payments to doctors draw scrutiny. Star Tribune September52008. (http://www.startribune.com/27942379.html) [Accessed April 9 2012]

23

Moses H IIIMartin JB: Academic relationships with industry: a new model for biomedical research. JAMA 285:9339352001

24

Okike KKocher MSMehlman CTBhandari M: Conflict of interest in orthopaedic research. An association between findings and funding in scientific presentations. J Bone Joint Surg Am 89:6086132007

25

Okike KKocher MSMehlman CTBhandari M: Industry-sponsored research. Injury 39:6666802008

26

Roach JWSkaggs DLSponseller PDMacleod LM: Is research presented at the scoliosis research society annual meeting influenced by industry funding?. Spine 33:220822122008

27

Rubenstein S: Grassley points to another academic doctor's industry pay. Wall Street Journal May282009. (http://blogs.wsj.com/health/2009/05/28/grassley-points-to-another-academic-doctors-pay-from-industry/) [Accessed April 9 2012]

28

Shah RVAlbert TJBruegel-Sanchez VVaccaro ARHilibrand ASGrauer JN: Industry support and correlation to study outcome for papers published in Spine. Spine 30:109911052005

29

Tolley K: What are Health Utilities? April2009. (http://www.whatisseries.co.uk/whatis/pdfs/What_are_health_util.pdf) [Accessed April 9 2012]

30

White APVaccaro ARZdeblick T: Counterpoint: physician-industry relationships can be ethically established, and conflicts of interest can be ethically managed. Spine 32:11 SupplS53S572007

31

Zuckerman JDPrasarn MKubiak ENKoval KJ: Conflict of interest in orthopaedic research. J Bone Joint Surg Am 86-A:4234282004

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 47 47 14
Full Text Views 114 114 29
PDF Downloads 103 103 7
EPUB Downloads 0 0 0

PubMed

Google Scholar